Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Genevieve Daune"'
Publikováno v:
Pharmacology & Toxicology. 73:29-34
Mice and chicken were given 5-fluoromethylornithine (5FMOrn), a selective inactivator of ornithine aminotransferase (OAT) over extended periods of time. This treatment allowed us to maintain elevated concentrations of ornithine in all tissues. Since
Publikováno v:
Metabolic brain disease. 8(3)
The vertebrate brain has the machinery to transport arginine and ornithine, and to form within nerve endings from these amino acids glutamate and GABA, the major excitatory and inhibitory neurotransmitters. Ornithine aminotransferase is a key enzyme
Publikováno v:
Biochemical Journal. 253:481-488
5-Fluoromethylornithine (5-FMOrn) is the first specific irreversible inhibitor of L-ornithine:2-oxoacid aminotransferase (OAT) found. Single doses (greater than 10 mg/kg) of this compound inactivate OAT to a residual OAT-like activity. This activity
Autor:
Donald M. Marcus, Norman Latov, Bart P. Hsi, Baiba K. Gillard, Jack Antel, Stanley Appel, Lanfranco Callegaro, Genevieve Daune, Baiba Gillard, Norman Latoy, Donald Marcus, Eduardo Nobile-Orazio, Alan Pestronk, Jacques Portoukalian, Richard Quarles, Edgar Salazar-Grueso, Larry Schneider, Michael Shy, Andreas Steck
Publikováno v:
Journal of neuroimmunology. 25(2-3)
Twelve laboratories from the United States, Canada, France, Italy and Switzerland participated in a workshop to compare assays used to measure anti-GM1 antibodies, and to discuss the clinical significance of these antibodies. A panel of test samples
Publikováno v:
Neurochemistry international. 10(3)
In this work new methods for the determination of ornithine (Orn) and l-ornithine:2-oxoacid aminotransferase (OAT) activity are described. These methods were used to demonstrate linear interrelationships between brain GABA and Orn concentrations. Bra
Publikováno v:
Life sciences. 45(11)
5-Fluoromethylornithine (5FMorn) is a specific inactivator of L-ornithine:2-oxoacid aminotransferase (OAT). Inactivation of OAT causes the enhancement of L-ornithine (Orn) concentrations in all tissues. Intraperitoneal or oral administration of 10–